There were 42,249 deaths due to opioid overdoses in 2016, compared to a projected 41,070 deaths from breast cancer in 2017 (42,640 in 2015). U.S. life expectancy has dropped for the second year in a row:
The increase largely stemmed from the continued escalation of deaths from fentanyl and other synthetic opioids, which jumped to 19,410 in 2016 from 9,580 in 2015 and 5,540 in 2014, according to a TFAH analysis of the report.
[...] The surge in overdose deaths has depressed recent gains in U.S. life expectancy, which fell to an average age of 78.6, down 0.1 year from 2015 and marking the first two-year drop since 1962-1963.
In a separate report, the CDC linked the recent steep increases in hepatitis C infections to increases in opioid injection.
Researchers used a national database that tracks substance abuse admissions to treatment facilities in all 50 U.S. states. They found a 133 percent increase in acute hepatitis C cases that coincided with a 93 percent increase in admissions for opioid injection between 2004 to 2014.
From the U.S. Centers for Disease Control and Prevention:
(Score: 2) by dry on Saturday December 23 2017, @06:06PM (1 child)
It is a market that is freer then most markets. The government interference is minimal between the sellers and buyers with the importers and distributors being regulated in the sense that they are banned but keep operating.
Lots of small sellers selling whatever is cheapest, mis-labeling their product, hard to double check the purity of their product and totally buyer beware philosophy. There's even quite a bit of freedom in the ways you can compete such as killing the competition.
(Score: 1) by khallow on Saturday December 23 2017, @11:41PM
Except when they throw people into jail which they do often. That makes it a lot less free than most markets.